Bothell-based BioLife Solutions posts earning results for 2016

BioLife Solutions is a Bothell-based company. Contributed art

The following is from a release by BioLife Solutions:

Bothell-based BioLife Solutions, Inc. has reported operational highlights and financial results for the fourth quarter and full year of 2016.

The company is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media.

Revenue from biopreservation media product sales reached a new high of $2.3 million in the fourth quarter of 2016, an increase of 24 percent over the same period in 2015. For the full year of 2016, revenue totaled a record $8.2 million, a 28 percent increase compared to $6.4 million in 2015. Revenue growth for both periods was driven by increased sales of CryoStor and HypoThermosol clinical grade biopreservation media products to the regenerative medicine segment, including increased order volume from later stage clinical customers that are developing CAR T-cell and other cellular immunotherapies for cancer and other leading causes of death.

“We are completely focused on executing our strategy to achieve our goal of positive quarterly EBITDAS by the end of the year,” said BioLife President and CEO Mike Rice. “We expect that a combination of continued revenue growth from the regenerative medicine market segment and lower operating expenses will enable BioLife to reach this milestone. 2017 could be a pivotal year for BioLife, with anticipated customer approvals of their cell therapies, and further adoption of CryoStor and HypoThermosol by new entrants in the high growth regenerative medicine market.”

2016 Operational Highlights

· 123 new customers were gained in 2016, including 65 in the high growth regenerative medicine market segment.

· Long term supply agreements were signed with Kite Pharma, Bellicum Pharmaceuticals, and TissueGene, illustrating our critical supplier role with these late stage clinical customers.

· Management estimates CryoStor and HypoThermosol are now incorporated in 250 regenerative medicine applications.

· Completed the restructuring of the biologistex JV with SAVSU, significantly reducing future cash outflows while maintaining a strong financial interest in the success of this disruptive cold chain management technology platform.

Q4 and 2016 Financial Results

· Gross margin was 61 percent for the fourth quarter and 58 percent for the full year of 2016.

· Total consolidated operating expenses for the fourth quarter were $2.0 million compared to $2.4 million in the third quarter of 2016. For the full year of 2016, consolidated operating expenses totaled $9.6 million compared to $8.8 million in 2015.

· Consolidated operating loss for the fourth quarter was $0.6 million compared to $1.1 million in the third quarter of 2016, and $1.4 million in the fourth quarter of 2015. Consolidated operating loss for the full year of 2016 was $4.9 million compared to $5.0 million in 2015.

· Net loss attributable to BioLife was $3.3 million for the fourth quarter of 2016, and included a one-time, non-cash loss on deconsolidation charge of $2.8 million related to the company’s restructuring of its biologistex joint venture. Excluding this charge, the net loss attributable to BioLife for the fourth quarter was $0.5 million compared to $1.1 million in the fourth quarter of 2015. Net loss attributable to BioLife for 2016 was $6.9 compared to $4.2 million in 2015. Excluding the one-time, non-cash loss on deconsolidation, net loss for 2016 was $4.1 million vs. $4.2 million in 2015.

2017 Catalysts:

· A number of cell therapy customers, including Kite Pharma, Kiadis Pharma and Kolon Life Sciences, are seeking regulatory approvals to commence marketing and commercial manufacturing in 2017, which, as a result, should drive increased demand for our proprietary biopreservation media products.

· Continued adoption of CryoStor and HypoThermosol in pre-IND validations and phase 1, 2 and 3 clinical trials of new cell and tissue based products and therapies.

· Adoption of the evo Smart Shipper and use of the biologistex Cold Chain Management SaaS by leading cell therapy companies.

2017 Guidance

Management reaffirms the full-year 2017 guidance provided in January as follows:

· Biopreservation media revenue is expected to grow between 20-25 percent over 2016, with revenue in excess of $10 million.

· Gross Margin is expected in a range of 55-60 percent.

· Annual operating expenses are expected to range from $8 to $9 million.

· Positive quarterly EBITDAS by the end of 2017.

More in Business

The new Bothell Friday Market will run from 3-8 p.m., every Friday through Sept. 27. Stephanie Quiroz/staff photo
New Bothell Friday Market opens

Bothell Friday Market will run every Friday through Sept. 27

Kiddie Academy locations on the Eastside win national recognition

Six locally owned educational child care centers received an award for brand excellence and customer service.

Selection and steady sales characterize local market

Buyers can enjoy additional selection this summer as they look for the home of their choice.

From left: Craig Olson, Joan Schrammeck, and Paula Paula DelGiudice with a solar panel. Stephanie Quiroz/staff photo
Little Bit in Redmond goes solar

Northwest Electric and Solar (NWES) of Kenmore donates a solar energy system to the therapeutic riding center.

Microsoft reveals project criteria for $500 million affordable housing funds

The company will soon accept applications for projects related to affordable housing on the Eastside.

Local real estate market brings more opportunities for buyers

Homebuyers are also benefiting from lower interest rates, which are currently are less than four percent.

Maurita Colburn, the chamber’s Member and Community Relations manager, welcomes Country Village owner Leeann Tesorieri as she receives a standing ovation from local business owners. Kailan Manandic/staff photo
Bothell Kenmore Chamber honors Country Village

The chamber awarded Country Village owner, Leeann Tesorieri, as member of the month.

Kailan Manandic/staff photo 
                                Bothell’s newest animal hospital opens with a joint celebration hosted by the Bothell Kenmore Chamber of Commerce.
Twin Pines Animal Hospital offers new vet services in Bothell

The animal hospital had been operating in the community for years before opening a new location.

The data visualized here was compiled from Apartment List’s monthly rent reports. See an interactive chart below. Kailan Manandic / data illustration
Eastside rental market could balance out with the region

Eastside rent medians increased by 2.8 in the past year, a decrease in growth from previous years.

Bothell’s Country Village opened in 1981 and offers around 40 small businesses a place to operate. It was thought to be closing this month, but recently announced shops will remain open until June 1. Aaron Kunkler / Bothell-Kenmore Reporter
Country Village announces some shops will remain open until June

The well-loved village announced the two-month extension for certain businesses two days after its supposed closure.

Work crews construct the first floor of Kenmore’s newest downtown development, the Flyway. The building is adjacent to the Hangar, Kenmore’s community center, and will be a mixed retail and residential space.
Kenmore’s newest downtown development breaks ground

The Flyway broke ground last week and aims to complete construction by February 2020.

Aaron Kunkler / Bothell-Kenmore Reporter 
                                Country Village is home to more than 40 local businesses. It is unclear whether these shops will secure new locations in Bothell before the center closes in April 2019.
Country Village closed after hosting local shops since 1985

The Country Village hosted about 40 local shops and restaurants before closing on March 31.